Qi Zhang

Cinda Fund Management Co. Ltd. (Cinda) is an asset management firm headquartered in Shenzhen, China. Formerly known as First State Cinda Fund Management Co. Ltd., the firm was founded in 2006 as a joint venture between China Cinda Asset Management Corp., an asset management firm controlled by the Government of China and the holder of a majority interest, and Colonial First State Global Asset Management Pty Ltd. which is the fund management arm and a wholly-owned subsidiary of the Commonwealth Bank of Australia (ASX: CBA). Cinda manages investment funds for retail investors.

ENSEM Therapeutics, Inc. is a drug discovery and development company that specializes in developing small molecule precision medicines for oncology. The company is based in Waltham, MA. The company leverages its unique Kinetic Ensemble® platform to develop innovative drugs. The company has a potential oral CDK2 inhibitor, PI3K?, and a number of early-stage discovery programs at various stages of maturity launched with their Kinetic Ensemble® platform. ENSEM Therapeutics was founded by Shenfang Jin, Qi Zhang, Cheng Luo, and Shenfang Jin has been the CEO since incorporation.